We demonstrate that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD capabilities in many different human and mouse immune cells; we provide evidence in their power to suppress inflammation in vivo As well as in clinical configurations; and we offer insights into their mechanism of motion. Our results set https://mannerss753raj2.scrappingwiki.com/user